Studies in Tay-Sachs diseases. III. Biochemistry. B. Catabolism of gangliosides and related compounds
Korey, S.R.; Stein, A.
Journal of Neuropathology and Experimental Neurology 22: 67-80
1963
ISSN/ISBN: 0022-3069 PMID: 14034773 Accession: 050405583
PDF emailed within 1 workday: $29.90
Related References
Berman, E.R.; Gatt, S. 1961: Studies on gangliosides of Tay-Sachs brain BULL RES COUNC ISRAEL SECT A CHEM 10A(l): 28-29Saifer, A.; Robin, M.; Volk, B.W. 1963: Chromatographic Studies of Normal and Tay-Sachs Gangliosides (Peptide-Strandin) Journal of Neurochemistry 10: 577-586
Pascal, T. A.; Saifer, A.; Gitlin, J. 1966: Immunochemical Studies on Normal and Tay-Sachs'Brain Gangliosides Experimental Biology and Medicine 121(3): 739-743
Pascal, T.A.; Saifer, A.; Gitlin, J. 1966: Immunochemical studies on normal and Tay-Sachs' brain gangliosides Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 121(3): 739-743
Saifer, A. ,; Volk, B.W. 1963: Chromatographic Studies of Normal and Tay-Sachs Gangliosides (Peptide-Strandin) Journal of Neurochemistry 10(8): 577-586
Gatt, S.; Berman, E.R. 1963: Studies on brain lipids in Tay-Sachs' disease. II. Solubility properties of gangliosides Journal of Neurochemistry 10: 65-72
Gatt, S.; Berman, E.R. 1963: Studies on brain lipids in Tay-Sachs' disease. III. Solubility properties of gangliosides Journal of Neurochemistry 10: 65-72
Trasler, J.; Saberi, F.; Somani, I.H.; Adamali, H.I.; Huang, J.Q.; Fortunato, S.R.; Ritter, G.; Gu, M.; Aebersold, R.; Gravel, R.A.; Hermo, L. 1998: Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides Endocrinology 139(7): 3280-3288
Jatzkewitz, H.; Mehl, E.; Sandhoff, K. 1970: Blocks in the catabolism of sulphatides and gangliosides as a cause of human neurological diseases Biochemical Journal 117(2): 6P-8P
Gatt, S. 1965: Studies on Brain Tissue of Tay-Sachs Disease IV. Partitioning of Gangliosides into a Chloroform-Rich Phase Journal of Neurochemistry 12(4): 311-321
Gatt, S. 1965: Studies on Brain Tissue of Tay-Sachs' Disease. Iv. Partitioning of Gangliosides into a Chloroform-Rich Phase Journal of Neurochemistry 12: 311-321
Evans, W.C. 1977: Biochemistry of the bacterial catabolism of aromatic compounds in anaerobic environments Nature 270(5632): 17-22
Korey, S.R.; Gonatas, J.; Stein, A. 1963: Studies on Tay-Sachs disease. III. Biochemistry. A. Analytic and metabolic aspects Journal of Neuropathology and Experimental Neurology 22: 56-66
Tallman, J.F.; Brady, R.O.; Quirk, J.M. 1972: The catabolism of tay sachs ganglioside in normal lysosomes and tay sachs brain lysosomes Federation Proceedings 31(2): 437
Arita, M.; Iwamori, M.; Higuchi, T.; Nagai, Y. 1983: Negative ion fast atom bombardment mass spectrometry of gangliosides and asialo gangliosides: a useful method for the structural elucidation of gangliosides and related neutral glycosphingolipids Journal of Biochemistry 94(1): 249-256
Spiegel Adolf, M.; Baird, H.W.; Cahill, J.; Cook, R. 1964: Lipoproteins in Tay-Sachs and related diseases Int Congr Biochem 6(7): 597
Cachón-González, M.ía.-B.ña.; Wang, S.Z.; Ziegler, R.; Cheng, S.H.; Cox, T.M. 2014: Reversibility of neuropathology in Tay-Sachs-related diseases Human Molecular Genetics 23(3): 730-748
Wagner, A. 1966: Concerning brain gangliosides in Tay-Sachs disease Klinische Wochenschrift 44(7): 398-402
Schneiderman, G.; Lowden, J.A.; Rae-Grant, Q. 1978: Tay-Sachs and related storage diseases: family planning Mental Retardation 16(1): 13-15
Bernheimer, H. 1968: Gangliosides in the cerebrospinal fluid and the Tay-Sachs disease Klinische Wochenschrift 46(5): 258-261